Case Report | Open Access
Thanyaporn Direksunthorn, "Melioidosis with Portal Vein Thrombosis", Case Reports in Infectious Diseases, vol. 2017, Article ID 2891510, 4 pages, 2017. https://doi.org/10.1155/2017/2891510
Melioidosis with Portal Vein Thrombosis
Melioidosis, caused by Burkholderia pseudomallei, is a common infectious disease in tropical regions. The author reports a case of melioidosis with a rare manifestation of portal vein thrombosis and cavernous transformation of the portal vein. Melioidosis should be considered a differential diagnosis in patients with underlying risk factors who present with multiple liver abscesses; moreover, portal vein thrombosis can be a potential complication. Computed tomography is the modality of choice to demonstrate venous thrombosis in various organs.
Melioidosis, caused by Burkholderia pseudomallei, is a common infectious disease in tropical and subtropical regions and is especially endemic in Southeast Asia . Since 1997, the number of melioidosis cases diagnosed in Thailand has been increasing , with approximately 1,000 deaths per year . The lung is the most commonly affected organ [4, 5], and the spleen is the most commonly affected intra-abdominal organ, followed by the liver and the kidney . Computed tomography (CT) can reveal the radiologic characteristics of melioid abscesses such as the “necklace sign” or the “honeycomb sign” . The author reports here a case of melioidosis with a rare manifestation of portal vein thrombosis.
2. Case Presentation
A written informed consent was obtained from the patient for publication of this case report and all accompanying images.
An otherwise healthy 54-year-old Thai farmer, a resident in Nakhon Si Thammarat, visited the emergency department because of persistent fever with right upper abdominal pain for 1 month. He had no medical or surgical history of note, in particular, and no known history of diabetes or immunosuppression. He sought local care and was given oral antibiotics and antipyretics, but his condition had not improved.
On arrival, he was febrile, icteric, and dehydrated. His body temperature was 38.9°C, blood pressure was 100/70 mmHg, respiratory rate was 30/min, and heart rate was 110/min. The liver was mildly enlarged. No cardiovascular or respiratory abnormality was found on physical examination.
Laboratory analysis showed the following: leukocytosis (total leukocyte count, 16,700 cells/mm3; segmented neutrophils, 80%); fasting blood sugar, 202 mg/dl; glycosylated hemoglobin (HbA1c), 12.8%; total bilirubin, 4.74 mg/dl; direct bilirubin, 3.49 mg/dl; alkaline phosphatase, 553 U/L; serum glutamic-oxaloacetic transaminase (SGOT), 27 U/L; and serum glutamic-pyruvic transaminase (SGPT), 39 U/L. Serum total protein and albumin levels were 7.2 and 3.6 g/dl, respectively. Results of coagulation tests of prothrombin time (PT) and international normalized ratio (INR) were within normal limits. Blood culture results showed Burkholderia pseudomallei.
His CT study showed multiple small liver abscesses, left portal vein thrombosis, and cavernous transformation of the portal vein (Figures 1 and 2). His pancreas and spleen appeared normal. Gallbladder wall congestion and periportal halo were also noted (Figure 3). The chest radiograph showed no pulmonary infiltration or nodule.
The treatment comprised an initial 2-week acute-phase intravenous therapy consisting of ceftazidime and metronidazole, followed by oral amoxicillin-clavulanic acid for 12 weeks, in addition to anticoagulants (daily subcutaneous injections of low molecular weight heparin). Percutaneous abscess drainage was not performed because of small abscesses and the patient’s positive response to antibiotics. Improvements in the patient’s abdominal pain and blood test results were obtained. A follow-up CT scan was done after 8 weeks of treatment, showing a completely recanalized left portal vein. At the 10-month follow-up after completion of the antibiotic course, the patient had totally recovered and no relapse had been documented. The patient was advised to avoid direct contact with soil or environmental water, to protect wounds from soil and water, and to avoid walking barefoot.
Burkholderia pseudomallei (formerly, Pseudomonas pseudomallei) is a bipolar-staining, Gram-negative aerobic bacillus and is found in tropical regions. Melioidosis occurs more frequently in patients with underlying diseases, such as diabetes, chronic renal failure, alcoholism, malignancy, and hematological diseases, including immunosuppression. This patient was first diagnosed with diabetes in this visit and it was noted that he worked as a farmer who sometimes walked barefoot on his cultivated land.
The author reports a case of melioidosis with a rare manifestation of portal vein thrombosis and cavernous transformation diagnosed based on CT findings. There are a few reported cases of melioidosis-associated venous thrombosis. Saïdani et al.  reported a case of disseminated melioidosis with pulmonary and liver abscesses, in addition to splenic vein thrombosis. Splenic vein thrombosis is also described in cases of melioidosis associated with pancreatic lesions . Niyasom et al.  reported a 42-year-old Thai man suffering from septicemic melioidosis with dural sinus thrombosis. The thrombotic events were possibly caused by an inflammatory response to systemic B. pseudomallei infection, leading to depletion of the natural endothelial modulators protein C, protein S, and antithrombin [10, 11]. LaRosa et al.  studied the correlation between inflammation and coagulation in melioidosis sepsis, revealing that consumption of endothelial modulators was a key feature of this process. Protein C was the modulator most profoundly affected, followed by antithrombin and protein S.
Cavernous transformation of the portal vein is a consequence of portal vein thrombosis and is the replacement of the normal single channel portal vein with numerous tortuous venous channels. Multiphase CT can be used to confirm the diagnosis as it demonstrates numerous vascular structures in the region of the portal vein, which are enhanced during the portal venous phase.
Saverymuttu et al.  reported that portal hypertension, not hypoalbuminemia, was the dominant factor causing gallbladder wall thickening in chronic liver disease. The CT image (Figure 3) showed gallbladder wall congestion (so-called congestive cholecystopathy) and a periportal halo. Periportal halos are defined as circumferential zones of low attenuation around the peripheral or subsegmental portal venous branches on contrast-enhanced CT. These halos represent fluid or dilated lymphatics in the loose areolar zone around the portal triad. This sign is nonspecific and can be seen in various conditions.
Transient hepatic attenuation differences (THAD) are localized mismatches in hepatic arterial and portal venous blood supply; often there is a relative increase in hepatic arterial supply, thereby giving a higher attenuation to the affected region. In this case the CT demonstrated higher attenuation in the left lobe of the liver than in the right lobe owing to left portal vein thrombosis.
Various causative organisms have been reported as causing portal vein thrombosis (Table 1).
Melioidosis should be considered as a differential diagnosis in patients with underlying risk factors who present with multiple liver abscesses; portal vein thrombosis can be a potential complication. Contrast-enhanced CT scan is the modality of choice to identify venous thrombosis in various organs.
Conflicts of Interest
The author declares that there are no conflicts of interest regarding the publication of this paper.
The author would like to thank the staff of the School of Medicine, Walailak University, for their support.
- N. J. White, “Melioidosis,” The Lancet, vol. 361, no. 9370, pp. 1715–1722, 2003.
- D. Limmathurotsakul, S. Wongratanacheewin, N. Teerawattanasook et al., “Increasing incidence of human melioidosis in northeast Thailand,” The American Journal of Tropical Medicine and Hygiene, vol. 82, no. 6, pp. 1113–1117, 2010.
- P. Chansrichavala, N. Wongsuwan, S. Suddee et al., “Public awareness of Melioidosis in Thailand and potential use of video clips as educational tools,” PLoS ONE, vol. 10, no. 3, Article ID e0121311, 2015.
- A. C. Cheng and B. J. Currie, “Melioidosis: epidemiology, pathophysiology, and management,” Clinical Microbiology Reviews, vol. 18, no. 2, pp. 383–416, 2005.
- B. J. Currie, S. P. Jacups, A. C. Cheng et al., “Melioidosis epidemiology and risk factors from a prospective whole-population study in northern Australia,” Tropical Medicine and International Health, vol. 9, no. 11, pp. 1167–1174, 2004.
- B. J. Currie, L. Ward, and A. C. Cheng, “The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study,” PLoS Neglected Tropical Diseases, vol. 4, no. 11, article e900, 2010.
- P. Apisarnthanarak, A. Thairatananon, K. Muangsomboon, D. S. K. Lu, L. M. Mundy, and A. Apisarnthanarak, “Computed tomography characteristics of hepatic and splenic abscesses associated with melioidosis: a 7-year study,” Journal of Medical Imaging and Radiation Oncology, vol. 55, no. 2, pp. 176–182, 2011.
- N. Saïdani, K. Griffiths, M. Million et al., “Melioidosis as a travel-associated infection: case report and review of the literature,” Travel Medicine and Infectious Disease, vol. 13, no. 5, pp. 367–381, 2015.
- V. H. Chong, K. S. Lim, and F. Sharif, “Pancreatic involvement in melioidosis,” Journal of the Pancreas, vol. 11, no. 4, pp. 365–368, 2010.
- S. Niyasom, P. Sithinamsuwan, C. Udommongkol, and J. Suwantamee, “Dural sinus thrombosis in melioidosis: the first case report,” Journal of the Medical Association of Thailand, vol. 89, no. 2, pp. 242–247, 2006.
- S. P. LaRosa, S. M. Opal, B. Utterback et al., “Decreased protein C, protein S, and antithrombin levels are predictive of poor outcome in Gram-negative sepsis caused by Burkholderia pseudomallei,” International Journal of Infectious Diseases, vol. 10, no. 1, pp. 25–31, 2006.
- S. H. Saverymuttu, A. Grammatopoulos, C. I. Meanock, J. D. Maxwell, and A. E. A. Joseph, “Gallbladder wall thickening (congestive cholecystopathy) in chronic liver disease: a sign of portal hypertension,” British Journal of Radiology, vol. 63, no. 756, pp. 922–925, 1990.
- A. Galloula, A. Rossi, V. Gautier, C. Minozzi, E. Messas, and T. Mirault, “Portal vein thrombosis associated with an acute cytomegalovirus infection,” Journal des Maladies Vasculaires, vol. 39, no. 3, pp. 224–230, 2014.
- F. Chelbi, D. Boutin-Le Thi Huong, M. Frigui, B. Asli, P. Hausfater, and J.-C. Piette, “Portal thrombosis complicating an acute cytomegalovirus infection in an immunocompetent patient,” La Revue de Médecine Interne, vol. 27, no. 1, pp. 54–58, 2006.
- J. L. Estival, P. Debourdeau, C. Zammit, L. Teixeira, S. Guérard, and B. Colle, “Spontaneous portal vein thrombosis associated with acute cytomegalovirus infection in an immunocompetent patient,” Presse Medicale, vol. 30, no. 38, pp. 1876–1878, 2001.
- U. M. Wariyapperuma and C. I. W. Jayasundera, “Peritoneal tuberculosis presenting with portal vein thrombosis and transudative Ascites—a diagnostic dilemma: case report,” BMC Infectious Diseases, vol. 15, no. 1, article 394, 2015.
- J. Kathwate and I. Shah, “Portal vein thrombosis as a complication of vancomycin resistant Staphylococcus aureas infection in an infant,” Sri Lankan Journal of Infectious Diseases, vol. 5, no. 1, pp. 28–31, 2015.
- E. Carnish, A. Garrett, and M. Slome, “A case of septic portal vein thrombosis (pylephlebitis),” The Medicine Forum, vol. 15, p. 21, 2015.
- M. Gajendran, T. Muniraj, and M. Yassin, “Diverticulitis complicated by pylephlebitis: a case report,” Journal of Medical Case Reports, vol. 5, article 514, 2011.
- L. Shahani and N. Khardori, “Fusobacterium necrophorum—beyond Lemierres syndrome,” BMJ Case Reports, vol. 2011, 2011.
Copyright © 2017 Thanyaporn Direksunthorn. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.